Inactive Instrument

Analyst Reco. HealthSouth Corp Nyse

Equities

US4219243098

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

Encompass Health Insider Sold Shares Worth $850,200, According to a Recent SEC Filing	25/05	MT
RBC Lifts Price Target on Encompass Health to $95 From $83, Cites 'Strong' Q1 Results, 2024 Guidance Boost; Outperform Kept	22/05	MT
Encompass Health Insider Sold Shares Worth $1,220,739, According to a Recent SEC Filing	07/05	MT
Encompass Health Insider Sold Shares Worth $3,745,152, According to a Recent SEC Filing	01/05	MT
UBS Adjusts Encompass Health Price Target to $96 From $88, Maintains Buy Rating	29/04	MT
Mizuho Adjusts Price Target on Encompass Health to $95 From $93, Keeps Buy Rating	25/04	MT
Barclays Raises Price Target on Encompass Health to $101 From $95, Maintains Overweight Rating	28/03	MT
UBS Adjusts Encompass Health Price Target to $88 From $84, Maintains Buy Rating	09/02	MT
Mizuho Raises Price Target on Encompass Health to $82 From $77, Keeps Buy Rating	09/02	MT
Deutsche Bank Adjusts Encompass Health Price Target to $83 From $77, Maintains Buy Rating	09/02	MT
RBC Raises Price Target on Encompass Health to $83 From $70, Cites 'Impressive Beat,' Guidance Boost; Outperform Kept	08/23/08	MT
Credit Suisse Adjusts Encompass Health's Price Target to $80 From $76, Keeps Outperform Rating	04/23/04	MT
Deutsche Bank Adjusts Encompass Health Price Target to $77 From $73, Maintains Buy Rating	03/23/03	MT
Truist Securities Adjusts Price Target on Encompass Health to $82 From $75, Maintains Buy Rating	03/23/03	MT
Mizuho Adjusts Price Target on Encompass Health to $77 From $74, Maintains Buy Rating	03/23/03	MT
Barclays Adjusts Price Target on Encompass Health to $71 From $61, Maintains Equal-Weight Rating	03/23/03	MT
UBS Adjusts Encompass Health Price Target to $84 From $77, Maintains Buy Rating	02/23/02	MT
Stephens Adjusts Price Target on Encompass Health to $78 From $74, Maintains Overweight Rating	29/23/29	MT
Raymond James Raises Price Target on Encompass Health to $80 From $72, Maintains Strong Buy Rating	02/23/02	MT
RBC Boosts Price Target on Encompass Health to $70 From $66, Maintains Outperform Rating	02/23/02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. HealthSouth Corp Nyse

Equities

US4219243098

Analyst Reco.

Filters